Metraipolis › archive › dc_29a98a2e18ee
Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential — Europe PMC PMID:41617027
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41617027
- DOI
- 10.1016/j.jbc.2026.111210
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T11:25:04.460Z
- SHA-256 of the archived text
307e9f39c10812d15ff007e78667ce8548667e3cacb85a0aec41b83eadfa83b0- Stable URL of this page
https://metraipolis.com/documento/dc_29a98a2e18ee
How to cite
Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential — Europe PMC PMID:41617027 — Europe PMC (en), https://europepmc.org/article/MED/41617027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_29a98a2e18ee (Metraipolis archive dc_29a98a2e18ee, sha256 307e9f39c10812d15ff007e78667ce8548667e3cacb85a0aec41b83eadfa83b0)
BibTeX
@misc{dc29a98a2e18ee,
title = {Engineered IgA-Fc fusion protein with bioactive nanobody neutralizes SARS-CoV-2 variants with mucosal delivery potential — Europe PMC PMID:41617027},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41617027},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_29a98a2e18ee; sha256 307e9f39c10812d15ff007e78667ce8548667e3cacb85a0aec41b83eadfa83b0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41617027. Agents can read the archived copy with the MCP tool read_document.